Vaccine

Synopsis:  The Therapeutic Goods Administration has provisionally approved the Comirnaty (Pfizer) vaccine as safe and effective for use among 5 to 11-year-old…

The European Union-wide rollout of Pfizer and BioNTech’s Covid-19 vaccine version for five- to 11-year-old children will begin Dec 13, one week…

Synopsis : Zydus Cadila’s COVID-19 vaccine ZyCoV-D will be initially introduced in seven States including Bihar, Jharkhand, Maharashtra, Punjab, Tamil Nadu, Uttar…

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of…

Pune-based Serum Institute of India (SII) is expected to supply 25 million doses to the Covax facility till December, as it looks…

Drug firm Zydus Cadila on Monday said it has received an order to supply one crore doses of its Covid-19 vaccine, ZyCoV-D,…

SUMMARY: WHO grant of EUL will ease international travel for those vaccinated with the Bharat Biotech`s Covaxin and the WHO clearance is a…

 KEYPOINTS: Australia’s medicines and medical devices regulator on Monday formally recognised India’s Covaxin, a vaccine against the coronavirus as the country’s border…

KEYPOINTS: Novavax Inc and partner Serum Institute of India said on Monday they received emergency use authorization for their Covid-19 vaccine in…

KEYPOINTS FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age. Effectiveness: Immune responses of children…